<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="description" content="Detailed lab packet for a ready-to-test Open Problem Collector experiment.">
<meta name="robots" content="index,follow">
<meta name="theme-color" content="#2563eb">
<link rel="icon" href="../favicon.svg" type="image/svg+xml">
<title>Functional Validation of Viral Type 2 IRES-Ribosome Interactions via Translation Assays — Lab Packet</title>
<style>  * { box-sizing: border-box; }
  body { margin: 0; font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, sans-serif; background: #f5f5f5; color: #111827; line-height: 1.5; }
  .container { max-width: 900px; margin: 0 auto; padding: 24px 16px 40px; }
  h1 { margin: 0 0 6px; font-size: 24px; }
  .subtitle { color: #4b5563; margin: 0 0 16px; font-size: 14px; }
  .nav { display: flex; gap: 10px; flex-wrap: wrap; margin-bottom: 20px; }
  .nav a { display: inline-block; padding: 6px 12px; border: 1px solid #d1d5db; border-radius: 7px; background: #fff; color: #1f2937; font-size: 13px; text-decoration: none; }
  .nav a:hover { border-color: #2563eb; color: #1d4ed8; }
  .meta { display: flex; gap: 8px; flex-wrap: wrap; margin-bottom: 16px; }
  .tag { display: inline-block; padding: 2px 8px; border-radius: 999px; font-size: 11px; font-weight: 600; }
  .tag-go { background: #dcfce7; color: #166534; }
  .tag-score { background: #dbeafe; color: #1e40af; }
  .tag-cost { background: #ecfeff; color: #155e75; }
  section { background: #fff; border: 1px solid #e5e7eb; border-radius: 10px; padding: 16px; margin-bottom: 12px; }
  section h2 { margin: 0 0 8px; font-size: 15px; text-transform: uppercase; letter-spacing: 0.5px; color: #374151; }
  section p { margin: 0 0 6px; font-size: 14px; }
  section ul, section ol { margin: 0 0 6px; padding-left: 18px; }
  section li { margin: 0 0 4px; font-size: 14px; }
  table { width: 100%; border-collapse: collapse; font-size: 13px; }
  th, td { border: 1px solid #e5e7eb; padding: 8px; text-align: left; vertical-align: top; }
  th { background: #f9fafb; font-size: 12px; text-transform: uppercase; letter-spacing: 0.4px; color: #4b5563; }
  .muted { color: #6b7280; font-size: 12px; margin-top: 8px; }
  .problem-box { background: #f9fafb; border-left: 3px solid #2563eb; padding: 12px; border-radius: 0 6px 6px 0; }
  .problem-box p { margin: 0 0 4px; font-size: 14px; }
  .problem-box .label { font-weight: 600; color: #374151; }
  @media (max-width: 800px) {
    table, thead, tbody, th, td, tr { display: block; }
    thead { display: none; }
    tr { margin-bottom: 10px; border: 1px solid #e5e7eb; }
    td { border: none; border-bottom: 1px solid #f3f4f6; }
    td:last-child { border-bottom: none; }
  }
</style>
</head>
<body>
<div class="container">
  <div class="nav">
    <a href="../go_now_lab_packets.html">All lab packets</a>
    <a href="../viewer.html">Assessment viewer</a>
    <a href="opc-go-002.html">&larr; Previous</a>
    <a href="opc-go-005.html">Next &rarr;</a>
  </div>

  <p class="muted">opc-go-006</p>
  <h1>Functional Validation of Viral Type 2 IRES-Ribosome Interactions via Translation Assays</h1>
  <div class="meta">
    <span class="tag tag-go">READY TO TEST</span>
    <span class="tag tag-score">Score 0.527</span>
    <span class="tag tag-cost">$8,500 &ndash; $15,000</span>
  </div>

  <section>
    <h2>Problem mapping</h2>
    <div class="problem-box">
      <p><span class="label">Problem:</span> Lack of complementary biochemical validation for the structural findings of viral Type 2 IRES recruitment to ribosomal preinitiation complex</p>
      <p><span class="label">Sub-question:</span> Do the structural observations correlate with functional translation activity in cellular or in vitro systems?</p>
    </div>
  </section>

  <section>
    <h2>Objective</h2>
    <p>Correlate structural observations of IRES-ribosome contacts with functional translation activity using in vitro and cellular reporter assays with site-directed IRES mutants.</p>
  </section>

  <section>
    <h2>Readouts</h2>
    <ul><li>Primary: Relative luciferase activity (firefly/renilla ratio) from bicistronic reporter constructs in mammalian cells, normalized to wild-type IRES</li><li>Secondary: In vitro translation efficiency measured by luciferase luminescence from rabbit reticulocyte lysate reactions with mutant vs wild-type IRES constructs</li><li>Secondary: Ribosome binding affinity (Kd values) determined by fluorescence polarization or biolayer interferometry for mutant vs wild-type IRES with 40S ribosomal subunits</li></ul>
  </section>

  <section>
    <h2>Experimental design</h2>
    <p><strong>Overview:</strong> Generate 8-12 site-directed IRES mutants targeting structurally-observed ribosome contact residues, then measure translation efficiency in parallel using dual-luciferase bicistronic reporters in HeLa cells and in vitro translation systems to establish structure-function relationships.</p>
    <ul><li>WP1: Design and generate IRES mutants (weeks 1-3) - identify 8-12 residues/domains from structural data making ribosome contacts, design mutations (alanine scanning, charge reversals, deletions), clone into bicistronic vectors (HCV-IRES, EMCV-IRES, or target Type 2 IRES) between renilla and firefly luciferase ORFs, sequence-verify all constructs</li><li>WP2: Cellular translation assays (weeks 4-7) - transfect HeLa and HEK293T cells with wild-type and mutant bicistronic reporters, harvest at 24h and 48h, measure dual-luciferase activity, perform dose-response with 3 plasmid concentrations, include cap-dependent translation control constructs</li><li>WP3: In vitro translation and binding assays (weeks 6-10) - transcribe IRES-firefly constructs in vitro, perform translation in rabbit reticulocyte lysate and wheat germ extract systems, measure time-course luciferase activity, purify 40S subunits from HeLa cells, perform fluorescence polarization binding assays with fluorescein-labeled IRES RNAs</li><li>WP4: Data integration and validation (weeks 11-12) - statistical analysis of all translation data, correlation analysis between structural contact distances and functional defects, Western blotting to confirm equal protein loading in cellular assays, RNA stability assays (Northern blot or RT-qPCR) to exclude RNA folding defects</li></ul>
    <p><strong>Controls:</strong></p>
    <ul><li>Positive control: Wild-type IRES sequence in bicistronic reporter, expected firefly/renilla ratio of 0.5-2.0 depending on IRES type</li><li>Negative control: Bicistronic construct with no IRES (empty intercistronic spacer), expected firefly/renilla ratio &lt;0.05, validates no cap-dependent reinitiation or cryptic IRES activity</li><li>Cap-dependent control: Monocistronic firefly luciferase under CMV promoter to normalize for transfection efficiency and general translation capacity</li><li>RNA stability control: Mutations in non-contact regions predicted by structure to have no ribosome interaction, should maintain wild-type translation levels</li></ul>
    <p><strong>Sample size plan:</strong> N=6 biological replicates per construct in cellular assays (3 independent transfections × 2 time points), N=4 technical replicates per construct in vitro translation assays, N=3 technical replicates for binding assays with triplicate measurements each</p>
    <p><strong>Success criteria:</strong></p>
    <ul><li>At least 50% of mutations targeting direct ribosome contact residues (as identified by &lt;5Å distance in structure) show &gt;2-fold reduction in translation efficiency with p&lt;0.01 vs wild-type</li><li>Correlation coefficient r&gt;0.6 between structural contact surface area (Å²) and functional translation defect (fold-change) across all mutants</li><li>Mutations in non-contact control regions maintain &gt;70% of wild-type translation activity, and RNA stability &gt;80% of wild-type by Northern blot or RT-qPCR</li><li>In vitro and cellular assay results show concordance with Pearson r&gt;0.5 for mutant phenotypes</li></ul>
    <p><strong>Estimated timeline:</strong> 12 weeks</p>
  </section>

  <section>
    <h2>Materials</h2>
    <table>
      <thead><tr><th>Item</th><th>Supplier</th><th>Catalog / ID</th><th>Link</th><th>Purpose</th></tr></thead>
      <tbody><tr>
          <td>Dual-Luciferase Reporter Assay System</td>
          <td>Promega</td>
          <td>E1910</td>
          <td></td>
          <td>Primary readout for cellular translation efficiency from bicistronic reporters</td>
        </tr><tr>
          <td>pRF bicistronic dual-luciferase vector</td>
          <td>Addgene</td>
          <td>#128654</td>
          <td></td>
          <td>Cloning backbone for IRES insertion between renilla and firefly luciferase genes</td>
        </tr><tr>
          <td>Q5 Site-Directed Mutagenesis Kit</td>
          <td>New England Biolabs</td>
          <td>E0554S</td>
          <td></td>
          <td>Generation of site-directed IRES mutations targeting ribosome contact residues</td>
        </tr><tr>
          <td>Rabbit Reticulocyte Lysate System</td>
          <td>Promega</td>
          <td>L4960</td>
          <td></td>
          <td>In vitro translation system for measuring IRES activity independent of cellular context</td>
        </tr><tr>
          <td>Wheat Germ Extract Translation System</td>
          <td>Promega</td>
          <td>L4380</td>
          <td></td>
          <td>Alternative in vitro translation system to validate findings across different lysate sources</td>
        </tr><tr>
          <td>HeLa S3 ribosome pellet or 40S purification kit</td>
          <td>Custom prep or BioVision</td>
          <td>K280 (isolation kit)</td>
          <td></td>
          <td>Source of mammalian 40S ribosomal subunits for direct binding assays</td>
        </tr><tr>
          <td>MEGAscript T7 Transcription Kit</td>
          <td>Invitrogen/Thermo</td>
          <td>AMB13345</td>
          <td></td>
          <td>In vitro transcription of IRES RNA constructs for translation and binding assays</td>
        </tr><tr>
          <td>Fluorescein RNA Labeling Kit</td>
          <td>Jena Bioscience</td>
          <td>NU-803-FL</td>
          <td></td>
          <td>Labeling IRES RNAs for fluorescence polarization binding assays</td>
        </tr><tr>
          <td>HeLa cells</td>
          <td>ATCC</td>
          <td>CCL-2</td>
          <td></td>
          <td>Primary cell line for cellular translation reporter assays</td>
        </tr><tr>
          <td>HEK293T cells</td>
          <td>ATCC</td>
          <td>CRL-3216</td>
          <td></td>
          <td>Secondary cell line to validate translation phenotypes across cell types</td>
        </tr><tr>
          <td>Lipofectamine 3000</td>
          <td>Invitrogen/Thermo</td>
          <td>L3000015</td>
          <td></td>
          <td>Transfection reagent for bicistronic reporter plasmids</td>
        </tr><tr>
          <td>BLItz Biolayer Interferometry System</td>
          <td>Sartorius/ForteBio</td>
          <td>45-5000</td>
          <td></td>
          <td>Alternative label-free method for measuring IRES-ribosome binding kinetics</td>
        </tr><tr>
          <td>Streptavidin Biosensors for BLItz</td>
          <td>Sartorius/ForteBio</td>
          <td>18-5019</td>
          <td></td>
          <td>Immobilization of biotinylated IRES RNA for binding measurements</td>
        </tr><tr>
          <td>Northern Max Kit</td>
          <td>Invitrogen/Thermo</td>
          <td>AM1940</td>
          <td></td>
          <td>RNA stability analysis to ensure mutations don&#x27;t destabilize IRES transcripts</td>
        </tr><tr>
          <td>96-well black plates for luminescence</td>
          <td>Corning</td>
          <td>3912</td>
          <td></td>
          <td>Plate format for high-throughput dual-luciferase measurements</td>
        </tr><tr>
          <td>GloMax Discover Multimode Microplate Reader</td>
          <td>Promega</td>
          <td>GM3000</td>
          <td></td>
          <td>Luminescence detection for luciferase assays and fluorescence polarization</td>
        </tr></tbody>
    </table>
    <p class="muted">Direct cost estimate: $8,500 &ndash; $15,000 (Includes molecular biology reagents (cloning, mutagenesis, transcription kits), translation lysates, luciferase assay kits for ~200 assays, cell culture reagents, RNA labeling, and binding assay consumables. Excludes equipment purchases (assumes access to plate reader and BLItz system), labor costs, sequencing fees ($150/construct), and ribosome purification if done commercially (~$2000). High estimate includes BLItz biosensors and commercial 40S subunit purchase.)</p>
  </section>

  <section>
    <h2>References</h2>
    <ul><li>Dual-Luciferase Reporter Assay: An Advanced Co-Reporter Technology Integrating Firefly and Renilla Luciferase Assays (Promega Technical Manual #TM040) &mdash; Standard protocol for bicistronic reporter assay optimization, normalization procedures, and troubleshooting guidelines for IRES-mediated translation measurements</li><li>Jaafar et al. 2016, &#x27;Structural Insights into mRNA Reading Frame Regulation by tRNA Modification and Slippery Codon-Anticodon Pairing&#x27; eLife, RNA binding and in vitro translation methods &mdash; Detailed protocols for in vitro translation optimization with different IRES elements and validation of translation initiation vs elongation defects</li><li>Ochs et al. 2012, &#x27;Assaying Viral IRES Activity&#x27; Methods in Molecular Biology 867:271-283 &mdash; Best practices for Type 2 IRES functional analysis including construct design, appropriate controls, and interpretation of bicistronic reporter data</li><li>Pisarev et al. 2008, &#x27;Specific functional interactions of nucleotides at key -3 and +4 positions flanking the initiation codon with components of the mammalian 48S translation initiation complex&#x27; Genes Dev, ribosome binding assay protocols &mdash; Methods for purifying mammalian 40S subunits and performing quantitative ribosome-RNA binding measurements using fluorescence-based approaches</li><li>Fukushi et al. 2001, &#x27;Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus&#x27; JBC 276:20824-20826 &mdash; Fluorescence polarization binding assay protocols adapted for IRES-ribosome interactions with calculation of dissociation constants</li></ul>
  </section>

  <section>
    <h2>Lab handoff checklist</h2>
    <ul><li>Structural coordinates (PDB file or CryoEM map) with annotated ribosome-IRES contact residues identified at &lt;5Å, &lt;8Å, and &lt;10Å distance thresholds, including contact surface area calculations and list of 12-15 candidate residues for mutagenesis prioritized by contact type (base-specific, backbone, protein contacts)</li><li>Complete wild-type IRES sequence (nucleotides) with secondary structure annotation, domain boundaries, and functional elements identified in literature, formatted for direct cloning into pRF vector between renilla and firefly luciferase genes with appropriate restriction sites or Gibson assembly overhangs</li><li>Mutagenesis strategy document specifying: (1) 8-12 target positions with rationale based on structural contacts, (2) specific mutations for each position (e.g., single nucleotide changes, small deletions, charge reversals), (3) 2-3 negative control mutations in non-contact regions, (4) predicted impact on RNA secondary structure using RNAfold or similar tool</li><li>Cell culture protocols including validated transfection conditions for HeLa and HEK293T cells with the specific bicistronic vector system, optimal plasmid amounts, and harvest timepoints from preliminary experiments or literature</li><li>Data analysis template with pre-defined normalization methods (firefly/renilla ratio calculation, fold-change relative to wild-type, statistical tests for N=6 replicates), correlation analysis pipeline for structure-function relationships, and figure templates for publication</li></ul>
  </section>

  <div class="nav" style="margin-top: 20px;">
    <a href="opc-go-002.html">&larr; Previous</a>
    <a href="../go_now_lab_packets.html">All lab packets</a>
    <a href="opc-go-005.html">Next &rarr;</a>
  </div>
</div>
</body>
</html>
